A Study of CS1001 in Subjects With Relapsed or Refractory Extranodal Natural Killer/ T Cell Lymphoma(ENKTL)

NCT03595657 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

Extranodal Natural Killer/T-Cell Lymphoma

Interventions

BIOLOGICAL: CS1001

Sponsor

CStone Pharmaceuticals